UK markets closed

Third Harmonic Bio, Inc. (THRD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
11.90-0.40 (-3.25%)
At close: 04:00PM EDT
11.83 -0.07 (-0.59%)
After hours: 04:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 485.01M
Enterprise value 219.89M
Trailing P/E 13.41
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.80
Enterprise value/revenue N/A
Enterprise value/EBITDA 4.25

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3160.39%
S&P500 52-week change 326.27%
52-week high 312.57
52-week low 34.31
50-day moving average 310.49
200-day moving average 38.60

Share statistics

Avg vol (3-month) 3155.17k
Avg vol (10-day) 3100.94k
Shares outstanding 540.76M
Implied shares outstanding 640.76M
Float 88.96M
% held by insiders 110.01%
% held by institutions 191.99%
Shares short (30 Apr 2024) 42.05M
Short ratio (30 Apr 2024) 410.71
Short % of float (30 Apr 2024) 411.25%
Short % of shares outstanding (30 Apr 2024) 45.03%
Shares short (prior month 28 Mar 2024) 4682.56k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-9.53%
Return on equity (ttm)-11.04%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -43.92M
Net income avi to common (ttm)-30.82M
Diluted EPS (ttm)-0.78
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)269.07M
Total cash per share (mrq)6.61
Total debt (mrq)3.95M
Total debt/equity (mrq)1.47%
Current ratio (mrq)50.28
Book value per share (mrq)6.71

Cash flow statement

Operating cash flow (ttm)-20.43M
Levered free cash flow (ttm)-18.04M